Physician
Carson Mcbeath & Boswell INC.
Carson Mcbeath & Boswell INC. was paid $3.07M by Medicaid between Jan 2018 and Nov 2024, across 18 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 35% of everything it billed.
33Billing provider infoCARSON MCBEATH & BOSWELL INC.
LONG BEACH, CA 90807
LONG BEACH, CA 90807
33aNPI1710970728assigned 08/24/2005
33bProvider typeOphthalmology Physician
28Total paid$3.07M
24GClaims43,447
24DCodes billed18
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in California
Rank by total paid#31 of 759
Median peer was paid$35K
This provider vs. median87×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,782 | $189K | |
| 2019 | 4,346 | $251K | |
| 2020 | 5,603 | $447K | |
| 2021 | 6,332 | $425K | |
| 2022 | 6,367 | $514K | |
| 2023 | 8,483 | $669K | |
| 2024incomplete | 6,534 | $577K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 35% | 9,537 | 8,417 | $1.07M |
| J0178 | Injection, aflibercept, 1 mg | 17% | 1,274 | 1,233 | $533K |
| 92134 | 12% | 16,036 | 15,726 | $378K | |
| J2778 | Injection, ranibizumab, 0.1 mg | 10% | 876 | 848 | $314K |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 8.5% | 537 | 537 | $262K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 7.6% | 5,750 | 5,583 | $232K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 4.3% | 3,584 | 3,561 | $133K |
| J9035 | Injection, bevacizumab, 10 mg | 1.8% | 893 | 868 | $55K |
| J7999 | Compounded drug, not otherwise classified | <1% | 1,662 | 1,637 | $30K |
| J3490 | Unclassified drugs | <1% | 46 | 41 | $22K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 381 | 381 | $15K |
| 92226 | <1% | 1,429 | 840 | $12K |
6 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARSON, STANLEY (PRESIDENT)